Before being routinely used in clinical practice, all hyperthermia apparatuses must be submitted to approval procedures including technical tests demonstrating histologically proven tissue destruction, double-blind clinical trials of safety and efficacy versus reference treatment. Refunding of these treatments by Social Security would increase medical expenditure.
Other output or dissemination activity: Not covered by health insurers.